These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30634049)

  • 1. Didymin by suppressing NF-κB activation prevents VEGF-induced angiogenesis in vitro and in vivo.
    Shukla K; Sonowal H; Saxena A; Ramana KV
    Vascul Pharmacol; 2019 Apr; 115():18-25. PubMed ID: 30634049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Didymin prevents hyperglycemia-induced human umbilical endothelial cells dysfunction and death.
    Shukla K; Sonowal H; Saxena A; Ramana KV
    Biochem Pharmacol; 2018 Jun; 152():1-10. PubMed ID: 29548811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vialinin A, an Edible Mushroom-Derived p-Terphenyl Antioxidant, Prevents VEGF-Induced Neovascularization In Vitro and In Vivo.
    Sonowal H; Shukla K; Kota S; Saxena A; Ramana KV
    Oxid Med Cell Longev; 2018; 2018():1052102. PubMed ID: 29541344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-angiogenic effect of Nelumbo nucifera leaf extracts in human umbilical vein endothelial cells with antioxidant potential.
    Lee JS; Shukla S; Kim JA; Kim M
    PLoS One; 2015; 10(2):e0118552. PubMed ID: 25714482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF-κB pathway.
    Watari K; Nakamura M; Fukunaga Y; Furuno A; Shibata T; Kawahara A; Hosoi F; Kuwano T; Kuwano M; Ono M
    Int J Cancer; 2012 Jul; 131(2):310-21. PubMed ID: 21826646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daphnetin inhibits TNF-α and VEGF-induced angiogenesis through inhibition of the IKKs/IκBα/NF-κB, Src/FAK/ERK1/2 and Akt signalling pathways.
    Kumar A; Sunita P; Jha S; Pattanayak SP
    Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):939-50. PubMed ID: 27297262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory and anti-angiogenic effects of flavonoids isolated from Lycium barbarum Linnaeus on human umbilical vein endothelial cells.
    Wu WB; Hung DK; Chang FW; Ong ET; Chen BH
    Food Funct; 2012 Oct; 3(10):1068-81. PubMed ID: 22751795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells.
    Palanisamy K; Nareshkumar RN; Sivagurunathan S; Raman R; Sulochana KN; Chidambaram S
    Microvasc Res; 2019 Mar; 122():136-145. PubMed ID: 30144414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo.
    Tammali R; Reddy AB; Srivastava SK; Ramana KV
    Angiogenesis; 2011 May; 14(2):209-21. PubMed ID: 21409599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular disrupting activity of combretastatin analogues.
    Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
    Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.
    Lien JC; Chung CL; Huang TF; Chang TC; Chen KC; Gao GY; Hsu MJ; Huang SW
    Br J Pharmacol; 2019 Oct; 176(20):4034-4049. PubMed ID: 31368127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPemd26, an anthraquinone derivative, suppresses angiogenesis via inhibiting VEGFR2 signalling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Br J Pharmacol; 2014 Dec; 171(24):5728-42. PubMed ID: 25091695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.
    Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP
    Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niclosamide inhibits the inflammatory and angiogenic activation of human umbilical vein endothelial cells.
    Huang M; Qiu Q; Zeng S; Xiao Y; Shi M; Zou Y; Ye Y; Liang L; Yang X; Xu H
    Inflamm Res; 2015 Dec; 64(12):1023-32. PubMed ID: 26499405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
    Dong F; Zhou X; Li C; Yan S; Deng X; Cao Z; Li L; Tang B; Allen TD; Liu J
    Cancer Biol Ther; 2014; 15(11):1479-88. PubMed ID: 25482945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oroxyloside inhibits angiogenesis through suppressing internalization of VEGFR2/Flk-1 in endothelial cells.
    Zhao K; Li X; Lin B; Yang D; Zhou Y; Li Z; Guo Q; Lu N
    J Cell Physiol; 2018 Apr; 233(4):3454-3464. PubMed ID: 28926106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.